株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ドライアイ症候群治療薬の世界市場:業界動向、市場シェア、市場規模、成長性、市場機会、および将来予測

Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 788436
出版日 ページ情報 英文 118 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
ドライアイ症候群治療薬の世界市場:業界動向、市場シェア、市場規模、成長性、市場機会、および将来予測 Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年02月11日 ページ情報: 英文 118 Pages
概要

当レポートでは、ドライアイ症候群治療薬の世界市場を取り上げ、業界動向や市場実績、価格動向、また市場競争状況など広範な調査に基づいて、SWOT分析、Porterのファイブフォース分析、バリューチェーン分析等の重要な市場分析結果を提供しています。さらに市場を疾患タイプ別、薬剤タイプ別、製品別、流通チャンネル別、および地域別に分類し、詳細な分析と将来予測を行っています。

第1章 前書き

第2章 調査範囲および調査手法

  • 調査目的
  • 利害関係者
  • データソース
  • 市場見積法
  • 予測手法

第3章 エグゼクティブ・サマリー

第4章 序論

  • 市場概要
  • 市場の特性
  • 主要業界動向

第5章 ドライアイ症候群治療薬世界市場

  • 市場概要
  • 市場実績
  • 疾患タイプ別市場分析
  • 薬剤タイプ別市場分析
  • 製品別市場分析
  • 流通チャンネル別市場分析
  • 地域別市場分析
  • 市場予測

第6章 疾患タイプ別市場分析

  • 乾性ドライアイ症候群治療薬
    • 市場動向
    • 市場予測
  • 涙液異常ドライアイ症候群治療薬

第7章 薬剤タイプ別市場分析

  • 潤滑点眼薬
    • 市場動向
    • 市場予測
  • 消炎性点眼薬
  • 自己血清点眼薬

第8章 製品別市場分析

  • 液体点眼薬
    • 市場動向
    • 市場予測
  • ジェル
  • 薬液ワイプ
  • 眼軟膏
  • その他

第9章 流通チャンネル別市場分析

  • 小売薬局
    • 市場動向
    • 市場予測
  • 病院薬局
  • オンライン薬店

第10章 地域別市場分析

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
  • アジア太平洋
  • 中東およびアフリカ
  • ラテンアメリカ

第11章 世界のドライアイ症候群治療薬産業:SWOT分析

第12章 世界のドライアイ症候群治療薬産業:バリューチェーン分析

第13章 世界のドライアイ症候群治療薬産業:Porterのファイブフォース分析

第14章 世界のドライアイ症候群治療薬産業:価格分析

  • 価格指標
  • 価格構造
  • 利幅分析

第15章 製造プロセス

  • 製品概要
  • 原材料の要件
  • 製造プロセス
  • 主要成功要素およびリスク要素

第16章 市場競争状況

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Novartis AG
    • Allergan plc.
    • 大塚ホールディングス株式会社
    • 参天製薬株式会社
    • Nicox S.A.
    • Auven Therapeutics
    • Akorn, Inc.
    • Bausch + Lomb
    • Alimera Science
    • GlaxoSmithKline plc
図表

List of Figures

  • Figure 1: Global: Dry Eye Syndrome Market: Major Drivers and Challenges
  • Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2013-2018
  • Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2018
  • Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2018
  • Figure 5: Global: Dry Eye Syndrome Market: Breakup by by Product (in %), 2018
  • Figure 6: Global: Dry Eye Syndrome Market: Breakup Distribution Channel (in %), 2018
  • Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2018
  • Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 9: Global: Dry Eye Syndrome Industry: SWOT Analysis
  • Figure 10: Global: Dry Eye Syndrome Industry: Value Chain Analysis
  • Figure 11: Global: Dry Eye Syndrome Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Dry Eye Syndrome (Evaporative Dry Eye Syndrome) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 13: Global: Dry Eye Syndrome (Evaporative Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 14: Global: Dry Eye Syndrome (Aqueous Dry Eye Syndrome) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 15: Global: Dry Eye Syndrome (Aqueous Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 16: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 17: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 19: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 20: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 21: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 22: Global: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 23: Global: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 24: Global: Dry Eye Syndrome (Gel) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 25: Global: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 26: Global: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 27: Global: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 28: Global: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 29: Global: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 30: Global: Dry Eye Syndrome (Other Product Types) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 31: Global: Dry Eye Syndrome (Other Product Types) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 32: Global: Dry Eye Syndrome Market: Sales through Retail Pharmacies (in Million US$), 2013 & 2018
  • Figure 33: Global: Dry Eye Syndrome Market Forecast: Sales through Retail Pharmacies (in Million US$), 2019-2024
  • Figure 34: Global: Dry Eye Syndrome Market: Sales through Hospital Pharmacies (in Million US$), 2013 & 2018
  • Figure 35: Global: Dry Eye Syndrome Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2019-2024
  • Figure 36: Global: Dry Eye Syndrome Market: Sales through Online Pharmacies (in Million US$), 2013 & 2018
  • Figure 37: Global: Dry Eye Syndrome Market Forecast: Sales through Online Pharmacies (in Million US$), 2019-2024
  • Figure 38: North America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 39: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 40: Europe: Dry Eye Syndrome Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 41: Europe: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 42: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 43: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 44: Middle East and Africa: Dry Eye Syndrome Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 45: Middle East and Africa: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 46: Latin America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 47: Latin America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 48: Dry Eye Syndrome Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Dry Eye Syndrome Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2019-2024
  • Table 3: Global: Dry Eye Syndrome Market Forecast: Breakup by by Drug Type (in Million US$), 2019-2024
  • Table 4: Global: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2019-2024
  • Table 5: Global: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
  • Table 6: Global: Dry Eye Syndrome Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 7: Dry Eye Syndrome: Raw Material Requirements
  • Table 8: Global: Dry Eye Syndrome Market Structure
  • Table 9: Global: Dry Eye Syndrome Market: Key Players
目次
Product Code: SR1018H15_Report

The global dry eye syndrome market was worth US$ 3.5 Billion in 2018. Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being fairly high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc. Looking forward, the market value is projected to reach US$ 5.1 Billion by 2024, exhibiting a CAGR of 6.5% during 2019-2024.

Market Summary:

Based on the disease type, the market has been segmented into evaporative dry eye syndrome and aqueous dry eye syndrome.

Based on the drug type, the market has been segmented into lubricant eye drops, anti-inflammatory drugs and autologous serum eye drops.

Based on the product type, the market has been segmented into liquid drops, gel, liquid wipes, eye ointment and others.

Based on the distribution channels, the market has been segmented into retail pharmacies, hospital pharmacies and online pharmacies.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

The competitive landscape of the market has also been examined with some of the key players being Novartis AG, Allergan plc., Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd., Nicox S.A., Auven Therapeutics, Akorn, Inc., Bausch + Lomb, Alimera Science and GlaxoSmithKline plc.

This report provides a deep insight into the global dry eye syndrome market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the dry eye syndrome market in any manner.

Key Questions Answered in This Report:

  • How has the global dry eye syndrome market performed so far and how will it perform in the coming years?
  • What is the breakup of the global dry eye syndrome market on the basis of region?
  • What is the breakup of the global dry eye syndrome market on the basis of disease type?
  • What is the breakup of the global dry eye syndrome market on the basis of drug type?
  • What is the breakup of the global dry eye syndrome market on the basis of product type?
  • What is the breakup of the global dry eye syndrome market on the basis of distribution channel?
  • What are the various stages in the value chain of the global dry eye syndrome market?
  • What are the key driving factors and challenges in the global dry eye syndrome market?
  • What is the structure of the global dry eye syndrome market and who are the key players?
  • What is the degree of competition in the global dry eye syndrome market?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Properties
  • 4.3. Key Industry Trends

5. Global Dry Eye Syndrome Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Disease Type
  • 5.4. Market Breakup by Drug Type
  • 5.5. Market Breakup by Product
  • 5.6. Market Breakup by Distribution Channels
  • 5.7. Market Breakup by Region
  • 5.8. Market Forecast

6. Market Breakup by Disease Type

  • 6.1. Evaporative Dry Eye Syndrome
    • 6.1.1. Market Trends
    • 6.1.2. Market Forecast
  • 6.2. Aqueous Dry Eye Syndrome
    • 6.2.1. Market Trends
    • 6.2.2. Market Forecast

7. Market Breakup by Drug Type

  • 7.1. Lubricant Eye Drops
    • 7.1.1. Market Trends
    • 7.1.2. Market Forecast
  • 7.2. Anti-inflammatory Drugs
    • 7.2.1. Market Trends
    • 7.2.2. Market Forecast
  • 7.3. Autologous Serum Eye Drops
    • 7.3.1. Market Trends
    • 7.3.2. Market Forecast

8. Market Breakup by Product

  • 8.1. Liquid Drops
    • 8.1.1. Market Trends
    • 8.1.2. Market Forecast
  • 8.2. Gel
    • 8.2.1. Market Trends
    • 8.2.2. Market Forecast
  • 8.3. Liquid Wipes
    • 8.3.1. Market Trends
    • 8.3.2. Market Forecast
  • 8.4. Eye Ointment
    • 8.4.1. Market Trends
    • 8.4.2. Market Forecast
  • 8.5. Others
    • 8.5.1. Market Trends
    • 8.5.2. Market Forecast

9. Market Breakup by Distribution Channel

  • 9.1. Retail Pharmacies
    • 9.1.1. Market Trends
    • 9.1.2. Market Forecast
  • 9.2. Hospital Pharmacies
    • 9.2.1. Market Trends
    • 9.2.2. Market Forecast
  • 9.3. Online Pharmacies
    • 9.3.1. Market Trends
    • 9.3.2. Market Forecast

10 Market Breakup by Region

  • 10.1. North America
    • 10.1.1. Market Trends
    • 10.1.2. Market Forecast
  • 10.2. Europe
    • 10.2.1. Market Trends
    • 10.2.2. Market Forecast
  • 10.3. Asia Pacific
    • 10.3.1. Market Trends
    • 10.3.2. Market Forecast
  • 10.4. Middle East and Africa
    • 10.4.1. Market Trends
    • 10.4.2. Market Forecast
  • 10.5. Latin America
    • 10.5.1. Market Trends
    • 10.5.2. Market Forecast

11 Global Dry Eye Syndrome Industry: SWOT Analysis

  • 11.1. Overview
  • 11.2. Strengths
  • 11.3. Weaknesses
  • 11.4. Opportunities
  • 11.5. Threats

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis

  • 13.1. Overview
  • 13.2. Bargaining Power of Buyers
  • 13.3. Bargaining Power of Suppliers
  • 13.4. Degree of Competition
  • 13.5. Threat of New Entrants
  • 13.6. Threat of Substitutes

14 Global Dry Eye Syndrome Industry: Price Analysis

  • 14.1. Price Indicators
  • 14.2. Price Structure
  • 14.3. Margin Analysis

15 Manufacturing Process

  • 15.1. Product Overview
  • 15.2. Raw Material Requirements
  • 15.3. Manufacturing Process
  • 15.4. Key Success and Risk Factors

16 Competitive Landscape

  • 16.1. Market Structure
  • 16.2. Key Players
  • 16.3. Profiles of Key Players
    • 16.3.1. Novartis AG
    • 16.3.2. Allergan plc.
    • 16.3.3. Otsuka Holdings Co., Ltd.
    • 16.3.4. Santen Pharmaceutical Co., Ltd.
    • 16.3.5. Nicox S.A.
    • 16.3.6. Auven Therapeutics
    • 16.3.7. Akorn, Inc.
    • 16.3.8. Bausch + Lomb
    • 16.3.9. Alimera Science
    • 16.3.10. GlaxoSmithKline plc
Back to Top